Regulation & law · 30/12/2022

National Cancer Institute to Grant Exclusive Patent License to Replay Holdings for Cancer Treatment

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Replay Holdings LLC, a biotech company based in San Diego, California, to develop and commercialize natural killer cell therapies for cancer treatment.